-
Loading metrics
ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile
-
Steven E. Kauder ,
Contributed equally to this work with: Steven E. Kauder, Tracy C. Kuo
Roles Conceptualization, Investigation, Methodology, Project administration, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing
Affiliation ALX Oncology, Burlingame, CA, United States of America
⨯ - Tracy C. Kuo ,
- Ons Harrabi,
- Amy Chen,
- Emma Sangalang,
- Laura Doyle,
- Sony S. Rocha,
- Sangeetha Bollini,
- Bora Han,
- Janet Sim,
- Jaume Pons,
- Hong I. Wan
http://orcid.org/0000-0003-4853-6544
ALX148 blocks CD47 and enhances innate and adaptive antitumor immunity with a favorable safety profile
- Steven E. Kauder,
- Tracy C. Kuo,
- Ons Harrabi,
- Amy Chen,
- Emma Sangalang,
- Laura Doyle,
- Sony S. Rocha,
- Sangeetha Bollini,
- Bora Han,
- Janet Sim
x
- Published: August 22, 2018
- https://doi.org/10.1371/journal.pone.0201832